First paper from my PhD out in @ACS_AMI. Great collaboration between @ImperialNHLI and @impchemistry! Happy to see this work finally published. Thankful for excellent students and academics who worked with me.
https://t.co/oAFODCtdcb
Review with @drphilmol on the contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
https://t.co/meuiK0od7L
@c_danmar@astro_jje @GeorgeOAllen @Brii_toe_knee I agree with you and the OP, but it can be useful to acknowledge that whilst coding itself isn’t necessarily a talent, there are traits one can have that you make you (more likely to be) good at coding. Conscientiousness definitely being one of them.
@astro_jje @GeorgeOAllen @Brii_toe_knee I fully endorse people being able to pursue whatever hobbies/skills they feel passionate about and would never discourage anyone from doing so. And hard work is pivotal to success, I was just acknowledging that some people are naturally better are things than others.
@0x49fa98@vgr@MimeticValue I agree, once a user reaches a critical mass of followers (approximately 1-2k) then I think it’s almost impossible to have a completely unacknowledged tweet. It can become more about the the person than the statement/opinion/idea itself
So proud of @ErinMGibson, @LiddelowSA et al, who persisted through nearly 7 years of work on this study. "Chemobrain" affects millions of cancer survivors. Through a better understanding of the pathophysiology, new treatment strategies will emerge. #glia
https://t.co/uAVXNSkjSh
The full peer-reviewed @sciencemagazine evaluation of #AlphaZero is here - a single algorithm that creatively masters chess, shogi and Go through self-play https://t.co/E3OPUOIFw4
Not all the T cells that are intratumoral are necessarily tumor reactive - that number is ~10%.
Might explain why even empirically "hot" tumors have variable response to ICIs. This is also pertinent to ongoing efforts at isolating TILs from solid tumors.
https://t.co/1scjSoZ1wg
Great to announce the SUMMIT study on BBC radio this morning. We will CT screen 25000 people in London for lung cancer and a further 25000 will be invited to help us develop a multi-cancer detection blood test working with a US company GRAIL @Peston@wellcometrust@CRUKresearch
Using AI to help scientists solve big questions is at the core of DeepMind’s mission. Today we’re delighted to announce our first significant milestone: a successful application of machine learning to the protein folding problem. https://t.co/PQO6WxKgEQ #AlphaFold (1/5)
In two different mouse models of #cancer, @Regeneron scientists found the dual treatment of PD-1 and GITR antibodies resulted in greater antitumor responses, compared to treatment with either antibody alone: https://t.co/Z0RqZ91k30
In this new Review, Pollard and Cassetta tell us about the different approaches to target and reprogramme pro-tumoural activities of tumour-associated macrophages https://t.co/h9qyLm49e4
For this #NationalNanoDay why not read some of our recent nanoscience and nanotechnology books? The first chapter of our professional reference books can be read for free through your Royal Society of Chemistry account https://t.co/yxz9mSc4BM
BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the #NobelPrize in Chemistry 2018 with one half to Frances H. Arnold and the other half jointly to George P. Smith and Sir Gregory P. Winter.